Cosmo

Pharma is a heavily regulated space, and the site needed to meet strict requirements around accessibility, testing and deployment without any of that showing in the finished product. At the same time, the content scope was substantial. We worked closely with Omse and the Cosmo team throughout, making sure everything landed correctly across a large and complex site.

The scale of the component library was the central challenge. With over thirty components and a large number of distinct page layouts, the system needed to behave consistently however it was assembled. Building that flexibility without introducing edge cases or visual inconsistency across hundreds of possible combinations required methodical thinking at every stage.

The investor section pulls real-time data into charts and programmatically fetches press releases, with content surfaced through Sanity. Keeping that data accurate and reliable, in a regulated environment where errors carry real consequences, meant the integrations needed to be robust from day one.

Operating in a regulated industry meant accessibility and deployment were non-negotiable. A thorough testing process and a fast, reliable deployment pipeline were built in throughout, not addressed at the end.